Dupilumab improves outcomes in patients with chronic rhinosinusitis with nasal polyps irrespective of gender: results from the SINUS‐52 trial.
Saved in:
| Title: | Dupilumab improves outcomes in patients with chronic rhinosinusitis with nasal polyps irrespective of gender: results from the SINUS‐52 trial. |
|---|---|
| Authors: | Fokkens, Wytske J1 (AUTHOR) w.j.fokkens@amsterdamumc.nl, Bachert, Claus2,3 (AUTHOR), Hopkins, Claire4 (AUTHOR), Marglani, Osama5,6 (AUTHOR), Praestgaard, Amy7 (AUTHOR), Nash, Scott8 (AUTHOR), Deniz, Yamo8 (AUTHOR), Rowe, Paul J9 (AUTHOR), Sacks, Harry8 (AUTHOR), Jacob‐Nara, Juby A9 (AUTHOR) |
| Source: | Clinical & Translational Immunology. 2024, Vol. 13 Issue 6, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
